5 results
To compare quality of life, cost-effectivenessand number of dissected mediastinal lymph node as a derivative oncologic outcome between open- and VATS lobectomy.
Research question and objectives: To explore whether genetic/genomic markers (alone or combined with clinical covariates) could be used to predict OS in NSCLC patients treated with Vargatef® according to the approved label.
The primary objective is to show that brain MRI surveillance alone is non-inferior in terms of overall survival (OS) to brain MRI surveillance combined with prophylactic cranial irradiation (PCI) for the treatment of small cell lung cancer (SCLC).
Determine the optimal set of implementation strategies to introduce ERATS in the Netherlands; evaluate whether high protocol adherence indeed leads to the expected reduction in length of hospital stay, complications, and readmissions, alongside…
To evaluate the performance of the GRAIL NSCLC ctDNA Assay when used to identify patients with stage I adenocarcinoma NSCLC who are ctDNA positive as part of the screening process for the clinical study TROPION-Lung12.